Stay updated with breaking news from Carlb Feldbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently issued reports on the stock. Morgan Stanley reduced their price objective on shares of Exelixis from $22.00 to $21.00 and […]
Exelixis (NASDAQ:EXEL – Get Rating) had its target price trimmed by Morgan Stanley from $22.00 to $21.00 in a research report released on Wednesday morning, The Fly reports. The brokerage currently has an equal weight rating on the biotechnology company’s stock. EXEL has been the topic of a number of other reports. Wells Fargo & […]
StockNews.com upgraded shares of Exelixis (NASDAQ:EXEL – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday. EXEL has been the subject of several other reports. EF Hutton Acquisition Co. I reiterated a buy rating and set a $24.00 target price on shares of Exelixis in a […]
Exelixis, Inc. (NASDAQ:EXEL – Get Rating) shares saw strong trading volume on Friday . 6,283,365 shares were traded during trading, an increase of 91% from the previous session’s volume of 3,282,271 shares.The stock last traded at $18.36 and had previously closed at $18.33. Analyst Upgrades and Downgrades A number of equities research analysts have recently […]
Should You Buy or Sell Exelixis Stock? Get The Latest EXEL Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.